Examining inflammation and biomarkers in organ transplant patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on adult patients who have undergone solid organ transplantation, including heart, liver, lung, and kidney transplants. It aims to measure various biological markers related to inflammation and cellular aging to identify patients at higher risk for transplant failure and other complications. The study will collect data on cytokines, inflammatory microRNAs, circulating free DNA, and epigenetic markers to help personalize immunosuppressive treatments and improve patient outcomes. The research is being conducted at the IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients (≥ 18 years old at the time of enrollment) who have undergone at least one of the following: Liver transplant, Kidney transplant, Heart transplant, Lung transplant during the study period.
* Informed consent acquisition.

Exclusion Criteria:

* none

Where it's running

• IRCCS - Azienda ospedaliero-universitaria di Bologna
  Bologna, Italy Recruiting
• IRCCS - Azienda ospedaliero-universitaria di Bologna
  Bologna, Italy Recruiting
• IRCCS - Azienda ospedaliero-universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Marco G Masetti, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Marco Masetti, MD
• Email: scompenso.trapiantocuore@aosp.bo.it
• Phone: 0512143725

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Dexcom G7 CGM in critically ill adults after major abdominal surgery or solid organ transplant

  This study tests how accurately the Dexcom G7 continuous glucose monitor tracks glucose in ICU patients after major abdominal surgery or solid organ transplantation who need tight insulin control.

  Recruiting Institute for Clinical and Experimental Medicine · Prague · NCT07611721

• Long-term health of children born to mothers who had a solid organ transplant

  This project will look for long-term heart, kidney, and immune system problems in people aged 16 and older who were born to mothers who had a kidney, liver, pancreas, heart, or lung transplant.

  Recruiting University Medical Center Groningen · Groningen, Provincie Groningen · NCT07291258

• Understanding the molecular causes and risks of kidney and related diseases

  This study is trying to understand the genetic and environmental factors that cause kidney diseases and their complications to help improve treatment and care for people at risk or already diagnosed.

  Recruiting University Hospital, Toulouse · Toulouse · NCT05318196

• Evaluating biomarkers in transplant recipients to enhance outcomes

  This study is testing if measuring certain proteins in blood and saliva can help doctors understand how well transplant medications are working for people who have received solid organ or bone marrow transplants.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT01163578

• Donor-derived virus-specific T cell therapy for CMV or adenovirus after organ or stem-cell transplant

  This tests donor-derived virus-specific T cells to treat CMV or adenovirus reactivation in people who have had a solid organ or stem-cell transplant.

  Recruiting Early Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio and 1 other locations · NCT03665675

• Education and a smartphone app to help organ transplant patients manage life, meds, and symptoms

  A smartphone app plus teaching materials are tested to see if they improve quality of life and adherence to immunosuppressive therapy for adults who have had a liver or kidney transplant.

  Recruiting Ondokuz Mayıs University · Samsun, Samsun · NCT07288918

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.